Clinical Trials Update: June 22, 2005
Hemodialysis Uterine Disorders Generalized Anxiety Disorder (GAD)
(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:
The purpose of this research study is to find out if linezolid is safe and effective in the treatment of catheter related gram-positive infections in the bloodstream. Linezolid (the study medication) will be compared to vancomycin/cefazolin (which are common treatments for this infection). You may be eligible to participate if you are 18 years or older, are on hemodialysis, have end stage renal disease, have a catheter-related infection, OR a fever OR a gram-positive blood culture. Research site located in New York, NY.
Do you suffer from anemia due to heavy uterine bleeding? If so, you may qualify to receive either IV medication or oral iron for your anemia. If you qualify, you will receive study related medical care and medication at no charge. Participants must be females 12 years of age or older, have a history of heavy uterine bleeding in the past six months and have a period duration exceeding 7 days. Research site located in Medford, Ore.
Generalized Anxiety Disorder (GAD)
The Anxiety Disorders Clinic at the New York State Psychiatric Institute invites you to participate in a research study of an investigational medication for Generalized Anxiety Disorder (GAD). GAD is characterized by excessive anxiety and worry that is difficult to control. If you are between 18 and 65 years old, and have been feeling anxious and worried about a number of things like health, finances, work, school, or relationships, you may qualify to participate. All study-related evaluations, laboratory tests, study medication, and visits are free. Research site located in New York, NY.
Copyright 2005 CenterWatch. All rights reserved.